ScholarLens Back to search
2011•AllergyRequires access

Treatment of respiratory allergy with allergy immunotherapy tablets

Claus Bachert

Open publisher page 5 citations

Abstract

To cite this article: Bachert C. Treatment of respiratory allergy with allergy immunotherapy tablets. Allergy 2011; 66 (Suppl. 95): 57–59. Abstract Allergy immunotherapy tablets (AIT) have expanded the treatment options for patients suffering from respiratory allergies. Efficacy is established in adults and children for two different commercially available grass AITs. The ALK grass AIT has an efficacy comparable to subcutaneous immunotherapy (SCIT), with a proven disease‐modifying effect after treatment completion. Safety profiles favour AIT over SCIT. Studies suggest that tablets in all aspects are superior to sublingual drops. AITs for other allergies including house dust mite and birch and ragweed pollen are in development.

About this research paper

What this paper is about

To cite this article: Bachert C. Treatment of respiratory allergy with allergy immunotherapy tablets. Allergy 2011; 66 (Suppl. 95): 57–59. Abstract Allergy immunotherapy tablets (AIT) have expanded the treatment options for patients suffering from respiratory allergies. Efficacy is established in adults and children for two different commercially available grass AITs. The ALK grass AIT has an efficacy comparable to subcutaneous immunotherapy (SCIT), with a proven disease‐modifying effect after treatment completion. Safety profiles favour AIT over SCIT. Studies suggest that tablets in all aspects are superior to sublingual drops. AITs for other allergies including house dust mite and birch and ragweed pollen are in development.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To cite this article: Bachert C. Treatment of respiratory allergy with allergy immunotherapy tablets. Allergy 2011; 66 (Suppl. 95): 57–59. Abstract Allergy immunotherapy tablets (AIT) have expanded the treatment options for patients suffering from respiratory allergies. Efficacy is established in adults and children for two different commercially available grass AITs. The ALK grass AIT has an efficacy comparable to subcutaneous immunotherapy (SCIT), with a proven disease‐modifying effect after treatment completion. Safety profiles favour AIT over SCIT. Studies suggest that tablets in all aspects are superior to sublingual drops. AITs for other allergies including house dust mite and birch and ragweed pollen are in development.

Key concepts: Respiratory allergy, Allergy, Medicine, Respiratory system, Immunotherapy, Dermatology, Asthma, Immunology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Treatment of respiratory allergy with allergy immunotherapy tablets — Research Paper | ScholarLens